These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 20517698)

  • 1. The prevalence and clinical correlates of metabolic syndrome in patients with schizophrenia: findings from a cohort in Turkey.
    Yazici MK; Anil Yağcioğlu AE; Ertuğrul A; Eni N; Karahan S; Karaağaoğlu E; Tokgözoğlu SL
    Eur Arch Psychiatry Clin Neurosci; 2011 Feb; 261(1):69-78. PubMed ID: 20517698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterizing coronary heart disease risk in chronic schizophrenia: high prevalence of the metabolic syndrome.
    Cohn T; Prud'homme D; Streiner D; Kameh H; Remington G
    Can J Psychiatry; 2004 Nov; 49(11):753-60. PubMed ID: 15633853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher prevalence of metabolic syndrome and related factors in patients with first-episode psychosis and schizophrenia: a cross-sectional study in Turkey.
    Sahpolat M; Ari M
    Nord J Psychiatry; 2021 Jan; 75(1):73-78. PubMed ID: 32886012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of prevalence of metabolic syndrome in bipolar disorder and schizophrenia from North India.
    Grover S; Nebhinani N; Chakrabarti S; Avasthi A; Kulhara P; Basu D; Mattoo SK; Malhotra S
    Nord J Psychiatry; 2014 Jan; 68(1):72-7. PubMed ID: 23293896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The prevalence of metabolic syndrome and related factors in patients with schizophrenia].
    Cerit C; Ozten E; Yildiz M
    Turk Psikiyatri Derg; 2008; 19(2):124-32. PubMed ID: 18561044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of metabolic syndrome among inpatients with schizophrenia.
    Boke O; Aker S; Sarisoy G; Saricicek EB; Sahin AR
    Int J Psychiatry Med; 2008; 38(1):103-12. PubMed ID: 18624022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevalence of metabolic syndrome in Spanish patients with schizophrenia and overweight. The CRESSOB Study].
    Gutiérrez-Rojas L; Azanza JR; Bernardo M; Rojo L; Mesa F; Martínez-Ortega JM
    Actas Esp Psiquiatr; 2014; 42(1):9-17. PubMed ID: 24504989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of coronary heart disease risk assessments among individuals with metabolic syndrome using three diagnostic definitions: a cross-sectional study from China.
    Zhou J; Gao Q; Wang J; Zhang M; Ma J; Wang C; Chen H; Peng X; Hao L
    BMJ Open; 2018 Oct; 8(10):e022974. PubMed ID: 30366915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of metabolic syndrome in obese children and adolescents using three different criteria and evaluation of risk factors.
    Sangun Ö; Dündar B; Köşker M; Pirgon Ö; Dündar N
    J Clin Res Pediatr Endocrinol; 2011; 3(2):70-6. PubMed ID: 21750635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic syndrome and cardiovascular risk among patients with schizophrenia receiving antipsychotics in Malaysia.
    Said MA; Sulaiman AH; Habil MH; Das S; Bakar AK; Yusoff RM; Loo TH; Bakar SA
    Singapore Med J; 2012 Dec; 53(12):801-7. PubMed ID: 23268153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of IDF, ATPIII and CDS in the diagnosis of metabolic syndrome among adult inhabitants in Jiangxi Province, China.
    Cheng L; Yan W; Zhu L; Chen Y; Liu J; Xu Y; Ji L; He J
    PLoS One; 2017; 12(12):e0189046. PubMed ID: 29216328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cannabis and schizophrenia: demographic and clinical correlates].
    Dervaux A; Laqueille X; Bourdel MC; Leborgne MH; Olié JP; Lôo H; Krebs MO
    Encephale; 2003; 29(1):11-7. PubMed ID: 12640322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of metabolic syndrome among patients with schizophrenia in Palestine.
    Sweileh WM; Zyoud SH; Dalal SA; Ibwini S; Sawalha AF; Ali I
    BMC Psychiatry; 2012 Dec; 12():235. PubMed ID: 23270504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and predictors of metabolic syndrome in patients with schizophrenia and healthy controls: A study in rural South Indian population.
    Rawat VS; Ganesh S; Bijjal S; Shanivaram Reddy K; Agarwal V; Devi R; Kumar CN; Christopher R; Thirthalli J
    Schizophr Res; 2018 Feb; 192():102-107. PubMed ID: 28454923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A follow-up study of metabolic syndrome in schizophrenia.
    Yoca G; Anıl Yağcıoğlu AE; Eni N; Karahan S; Türkoğlu İ; Akal Yıldız E; Mercanlıgil SM; Yazıcı MK
    Eur Arch Psychiatry Clin Neurosci; 2020 Aug; 270(5):611-618. PubMed ID: 31030256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of schizophrenia outpatients treated with antipsychotics with and without metabolic syndrome: findings from the CLAMORS study.
    Arango C; Bobes J; Aranda P; Carmena R; Garcia-Garcia M; Rejas J;
    Schizophr Res; 2008 Sep; 104(1-3):1-12. PubMed ID: 18606526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of metabolic syndrome prevalence in patients with schizophrenia and bipolar I disorder.
    Nayerifard R; Bureng MA; Zahiroddin A; Namjoo M; Rajezi S
    Diabetes Metab Syndr; 2017 Nov; 11 Suppl 1():S411-S416. PubMed ID: 28927969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of metabolic syndrome among patients with schizophrenia in Japan.
    Sugawara N; Yasui-Furukori N; Sato Y; Umeda T; Kishida I; Yamashita H; Saito M; Furukori H; Nakagami T; Hatakeyama M; Nakaji S; Kaneko S
    Schizophr Res; 2010 Nov; 123(2-3):244-50. PubMed ID: 20850274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of metabolic syndrome in an elderly community: comparison between three diagnostic methods.
    Rigo JC; Vieira JL; Dalacorte RR; Reichert CL
    Arq Bras Cardiol; 2009 Aug; 93(2):85-91. PubMed ID: 19838483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic syndrome in schizophrenia: a comparative study of antipsychotic-free/naïve and antipsychotic-treated patients from India.
    Pallava A; Chadda RK; Sood M; Lakshmy R
    Nord J Psychiatry; 2012 Jun; 66(3):215-21. PubMed ID: 22017264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.